3rd Biologics Manufacturing Asia 2016

We are very happy to announce that Pharma China is a supporting media partner at the 3rd Biologics Manufacturing Asia 2016 conference taking place in Singapore between the 29th of February and 1st of March 2016.

Some of the confirmed speakers include:

Allison Moore, Senior Vice President, Process Development, Amgen, USA

Parimal Desai, VP,  Global Vaccines & Biologics Commercialization, Merck Manufacturing Division, USA

Senthil Ramaswamy, Director, MSAT, Lonza, Singapore

Srinivasan Raman, Vice President and Head of Biocon Malaysia Operations, Biocon Sdn BhD, Malaysia

Peter Turecek, ​Senior Director, Global Medical Affairs, Senior Scientific Advisor, BAXALTA AUSTRIA

Alois Jungbauer, Laboratory of Protein Technolog and Downstream Processing, AUSTRIAN CENTER OF BIOTECHNOLOGY, AUSTRIA

Villoo Patel, Chairman and Managing Director of Avesthagen, India

Ho Jung Oh, Viral Vaccines Team Leader, MINISTRY OF FOOD AND DRUG SAFETY, KOREA

Steffen Goletz, CEO, CSO, Glycotope GmbH, Germany

Wenshan Lee, Vice President, Process Development, Elevant Biopharma, Taiwan

Rudiger Mechnser, Principal Engineer, Samsung Engineering, Korea

Eric Tsao, Chief Executive Officer, Synermore, USA

Song Zhiwei, Principal Scientist, Bioprocessing Technology Institute, Singapore

Gyun Min Lee, Professor, Korea Advanced Institute of Science and Technology, Korea

Some of the themes that would be discussed include:

Biomanufacturing Excellence: Flexible manufacturing, modular smart facilities, single use, shift from batch to continuous manufacturing, Novel technologies and how it will revolutionize biomanufacturing in the next few years.

Upstream Processing: Optimized large scale cell culture performance, high-throughput media selection and optimization, reducing cell-line characterization timelines.

Downstream Processing: Continuous DSP and process economy maximization, advances in downstream disposables, viral Clearance strategies & regulations.

PAT, QbD and automation of process design.